The Maillard reaction inhibitors and their biological and therapeutic significance
- PMID: 15323184
The Maillard reaction inhibitors and their biological and therapeutic significance
Abstract
The formation of AGE crosslinks as a result of the Maillard reaction is reduced by several drugs (aminoguanidine, OPB-9195, tenilsetam, aspirin), substances of natural origin (carnosine, homocarnosine) and antioxidants. These compounds are the Maillard reaction inhibitors, but do not seem to break AGE-derived protein crosslinks, which have already formed and therefore will not be effective in patients with a long history of the disease. The first in a new class of compounds that have been shown the ability to chemically reverse the Maillard reaction is PTB. This compound breaks the carbon-carbon bond between two carbonyls of glucose-derived protein crosslinks.
Similar articles
-
The Maillard reaction and its consequences for a living body.Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):159-62. Ann Univ Mariae Curie Sklodowska Med. 2003. PMID: 15323185 Review.
-
Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.Arch Biochem Biophys. 1999 Aug 1;368(1):98-104. doi: 10.1006/abbi.1999.1291. Arch Biochem Biophys. 1999. PMID: 10415116
-
Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes.Arch Biochem Biophys. 1996 Jan 15;325(2):152-8. doi: 10.1006/abbi.1996.0019. Arch Biochem Biophys. 1996. PMID: 8561492
-
A quantitative model of the generation of N(epsilon)-(carboxymethyl)lysine in the Maillard reaction between collagen and glucose.Biochem J. 2003 Nov 15;376(Pt 1):109-21. doi: 10.1042/BJ20030496. Biochem J. 2003. PMID: 12911334 Free PMC article.
-
Maillard reaction products in tissue proteins: new products and new perspectives.Amino Acids. 2003 Dec;25(3-4):275-81. doi: 10.1007/s00726-003-0017-9. Epub 2003 Jul 29. Amino Acids. 2003. PMID: 14661090 Review.